Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
Go back to Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial| Asianada, Inc. (NASDAQ: ASND) | Delayed: 253.27 +1.34 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $251.93 | 52 Week High | $21.79 | |||
| Open | $251.55 | 52 Week Low | $11.92 | |||
| Day High | $256.09 | P/E | N/A | |||
| Day Low | $249.99 | EPS | $-0.07 | |||
| Volume | 153,154 | |||||
